Get the Stockscreener App
1.76
11.39%
0.18
After Hours:
1.82
0.06
+3.41%
Intelligent Bio Solutions Inc stock is traded at $1.76, with a volume of 516.73K.
It is up +11.39% in the last 24 hours and up +25.71% over the past month.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment).
See More
Previous Close:
$1.58
Open:
$1.65
24h Volume:
516.73K
Relative Volume:
4.04
Market Cap:
$8.46M
Revenue:
$3.19M
Net Income/Loss:
$-10.42M
P/E Ratio:
-0.0496
EPS:
-35.4757
Net Cash Flow:
$-10.65M
1W Performance:
+21.38%
1M Performance:
+25.71%
6M Performance:
+25.09%
1Y Performance:
-29.60%
1-Day Range:
$1.60
$1.80
1-Week Range:
$1.34
$1.80
52-Week Range:
$1.00
$11.70
Intelligent Bio Solutions Inc Stock (INBS) Company Profile
Name
Intelligent Bio Solutions Inc
Sector
Industry
Phone
646-233-6971
Address
135 W 41ST ST,, NEW YORK
Compare INBS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INBS
Intelligent Bio Solutions Inc
|
1.76 | 8.46M | 3.19M | -10.42M | -10.65M | -35.48 |
|
ABT
Abbott Laboratories
|
127.93 | 221.89B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
102.36 | 150.86B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
391.29 | 149.17B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
90.82 | 116.46B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
72.45 | 42.73B | 6.60B | 4.16B | 490.10M | 6.93 |
Intelligent Bio Solutions Inc Stock (INBS) Latest News
INBS drug screening system to support multiple languages By Investing.com - Investing.com Australia
Fingerprinting Drug Screening Systems - Trend Hunter
Intelligent Bio Solutions Expands Fingerprinting System Globally - TipRanks
Intelligent Bio Solutions Expands Global Reach with Multilingual Drug Screening System Upgrade - The Manila Times
Revolutionary Fingerprint Drug Test Goes Global: Multi-Language Update Opens Door to 4 Billion Users - StockTitan
Global Drug Screening Market Is Forecasted to Reach $19.5 Billion By 2029 - GlobeNewswire
Intelligent Bio Solutions Expands with UK Partnership - TipRanks
Intelligent Bio Solutions Adds Quantum TM to 400+ Account Portfolio Utilizing Breakthrough Fingerprint Drug Testing - The Manila Times
Revolutionary Fingerprint Drug Test Wins Major UK Contract, US Launch Next - StockTitan
EXCLUSIVE: Intelligent Bio Solutions Partners With UK-Based Quantum TM For Fingerprint Drug Testing At 10 Sites - AOL
Intelligent Bio Solutions Partners with IVY Diagnostics - TipRanks
EXCLUSIVE: Intelligent Bio Solutions Partners With IVY Diagnostics, Seeks Expansion In Europe's $3.6 Billion Drug Screening Market - AOL
Intelligent Bio Solutions Partners with IVY Diagnostics to Expand in Europe's $3.6 Billion Drug Screening Market and in Middle Eastern Regions - The Manila Times
Revolutionary Fingerprint Drug Test Wins Italian Police Contract, Set to Transform Road Safety - StockTitan
Intelligent Bio Solutions (NASDAQ:INBS) Stock Quotes, Forecast and News Summary - Benzinga
Intelligent Bio Solutions Inc. (NASDAQ:INBS) Short Interest Update - Defense World
Intelligent Bio Solutions Partners with Princebuild to Transition from Saliva Testing to Fingerprint Sweat-Based Drug Screening Across its Seven UK Sites - The Manila Times
Intelligent Bio Solutions Expands UK Reach as Princebuild Adopts Revolutionary Fingerprint Drug Test - StockTitan
Intelligent Bio Solutions Releases Positive PK Study Results - MPO-mag
Intelligent Bio Solutions (NASDAQ:INBS) Shares Down 2.1% – Should You Sell? - Defense World
Intelligent Bio Solutions expands share count to over 4.8 million - Investing.com
Intelligent Bio Solutions expands share count to over 4.8 million By Investing.com - Investing.com UK
How maker of drug tests Intelligent Bio Solutions builds its business on people’s tendency to lie - Kursiv Media
Intelligent Bio Solutions Submits FDA Premarket Notification - TipRanks
Intelligent Bio Gains On Applying For Fingerprinting Review - Barchart
Intelligent Bio Gains on Applying for Fingerprinting Review - Baystreet.ca
INBS seeks FDA clearance for fingerprint drug test - Investing.com
Intelligent Bio Solutions Inc. Submits FDA 510(k) Application for Intelligent Fingerprinting Drug Screening System - Nasdaq
Intelligent Bio Solutions Announces 510(k) Submission to US - GlobeNewswire
Intelligent Bio Solutions Files FDA Application for 94% Accurate 10-Minute Drug Screening Breakthrough - StockTitan
Intelligent Bio Solutions Announces Positive Results of PK Study, a Key Milestone on Path to FDA 510(k) Submission - Marketscreener.com
LVIS Corporation Unveils Cloud-Based Platform for EEG Diagnostics - MPO-mag
Intelligent Bio Solutions to Host Virtual Fireside Chat on Wednesday, December 11th at 4:30 p.m. ET - Marketscreener.com
Intelligent Bio Solutions CEO to Discuss FDA Path & Clinical Results in Upcoming Fireside Chat - StockTitan
Intelligent Bio Solutions Releases Business Operations Presentation - TipRanks
Intelligent Bio Solutions completes fingerprint drug screening system study - MSN
Intelligent Bio Solutions Advances Fingerprint Drug Testing - TipRanks
Intelligent Bio : Achieves 94.1% Accuracy in Method Comparison Study, Following Positive PK Study Results Form 8 K - Marketscreener.com
Intelligent Bio Solutions Achieves 94.1% Accuracy in Method Comparison Study, Following Positive PK Study Results - The Manila Times
Intelligent Bio Solutions Hits 94% Accuracy in Drug Screening Breakthrough Study - StockTitan
Intelligent Bio Solutions to Participate in the Noble Capital Markets 20th Annual Emerging Growth Equity Conference - Marketscreener.com
Intelligent Bio Solutions to Participate in the Noble Capital Markets' 20th Annual Emerging Growth Equity Conference - The Manila Times
Intelligent Bio Solutions to Participate in the Noble Capital Markets’ 20th Annual Emerging Growth Equity Conference - Marketscreener.com
Intelligent Bio Solutions to Present at Noble Capital's 2024 Growth Conference | INBS Stock News - StockTitan
Intelligent Bio Solutions raises $250k via stock sales - Investing.com
Intelligent Bio Solutions raises $250k via stock sales By Investing.com - Investing.com Canada
INBS (Intelligent Bio Solutions) Peter Lynch Fair Value : $-443.54 (As of Nov. 21, 2024) - GuruFocus.com
Intelligent Bio Solutions Inc Stock (INBS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):